Compound 18a5
Product Specifications
Bioactivity
Compound 18a5 was demonstrated to be a promising lead compound for the treatment of TNBC by degrading ANXA3.
Smiles
O=C(CSC(NC1C(N(C(C)C)C(C=CC=C2)=C2C(C3=CC=CC=C3)=N1)=O)=S)N(CC4)CCN4C5=NC=CC=C5
Molecular Formula
C30H32N6O2S2
Molecular Weight
572.74
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC208398L1V 200 µL
Munc18c (STXBP3) (NM_007269) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
041460-AP 200 µL
SCLT1, CT (SCLT1, SAP1, Sodium channel and clathrin linker 1, Sodium channel-associated protein 1) (AP) discontinued
Ask
View Details GTR15328369 1 Vial
Lentiviral human RAB15 shRNA (UAS) - Lentiviral human RAB15 shRNA (UAS, GFP) plasmid
Ask
View Details